| Uncoupling environmental pH and intrabacterial acidification from pyrazinamide susceptibility in Mycobacterium tuberculosis ND Peterson, BC Rosen, NA Dillon, AD Baughn Antimicrobial agents and chemotherapy 59 (12), 7320-7326, 2015 | 96 | 2015 |
| Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide NA Dillon, ND Peterson, BC Rosen, AD Baughn Antimicrobial agents and chemotherapy 58 (12), 7258-7263, 2014 | 89 | 2014 |
| Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA NA Dillon, ND Peterson, HA Feaga, KC Keiler, AD Baughn Scientific reports 7 (1), 6135, 2017 | 81 | 2017 |
| The fatty acid oleate is required for innate immune activation and pathogen defense in Caenorhabditis elegans SM Anderson, HK Cheesman, ND Peterson, JE Salisbury, AA Soukas, ... PLoS pathogens 15 (6), e1007893, 2019 | 70 | 2019 |
| Alfalfa Sprouts--Arizona, California, Colorado, and New Mexico, February-April 2001. J Mohle-Boetani, B Werner, M Polumbo, J Farrar, D Vugia, S Anderson, ... JAMA: Journal of the American Medical Association 287 (5), 2002 | 68 | 2002 |
| Innate immunity in the C. elegans intestine is programmed by a neuronal regulator of AWC olfactory neuron development KJ Foster, HK Cheesman, P Liu, ND Peterson, SM Anderson, ... Cell reports 31 (1), 2020 | 56 | 2020 |
| The nuclear hormone receptor NHR-86 controls anti-pathogen responses in C. elegans ND Peterson, HK Cheesman, P Liu, SM Anderson, KJ Foster, R Chhaya, ... PLoS genetics 15 (1), e1007935, 2019 | 53 | 2019 |
| Caenorhabditis elegans in high-throughput screens for anti-infective compounds ND Peterson, R Pukkila-Worley Current opinion in immunology 54, 59-65, 2018 | 49 | 2018 |
| Pathogen infection and cholesterol deficiency activate the C. elegans p38 immune pathway through a TIR-1/SARM1 phase transition ND Peterson, JD Icso, JE Salisbury, T Rodríguez, PR Thompson, ... Elife 11, e74206, 2022 | 42 | 2022 |
| Ribosome Rescue Inhibitors Kill Actively Growing and Nonreplicating Persister Mycobacterium tuberculosis Cells JN Alumasa, PS Manzanillo, ND Peterson, T Lundrigan, AD Baughn, ... ACS Infectious Diseases 3 (9), 634-644, 2017 | 40 | 2017 |
| Long-chain fatty acyl coenzyme A ligase FadD2 mediates intrinsic pyrazinamide resistance in Mycobacterium tuberculosis BC Rosen, NA Dillon, ND Peterson, Y Minato, AD Baughn Antimicrobial agents and chemotherapy 61 (2), 10.1128/aac. 02130-16, 2017 | 28 | 2017 |
| Non-canonical pattern recognition of a pathogen-derived metabolite by a nuclear hormone receptor identifies virulent bacteria in C. elegans ND Peterson, YT Samantha, QJ Huang, KA Wani, CA Schiffer, ... Immunity 56 (4), 768-782. e9, 2023 | 25 | 2023 |
| Ether lipid biosynthesis promotes lifespan extension and enables diverse pro-longevity paradigms in Caenorhabditis elegans L Cedillo, FM Ahsan, S Li, NL Stuhr, Y Zhou, Y Zhang, A Adedoja, ... Elife 12, e82210, 2023 | 16 | 2023 |
| Intestinal immunity in C. elegans is activated by pathogen effector-triggered aggregation of the guard protein TIR-1 on lysosome-related organelles Y Samantha, KA Wani, ND Peterson, A Page, F Humphries, ... Immunity 57 (10), 2280-2295. e6, 2024 | 1 | 2024 |
| Activation of intestinal immunity by pathogen effector-triggered aggregation of lysosomal TIR-1/SARM1 SY Tse-Kang, KA Wani, ND Peterson, A Page, R Pukkila-Worley bioRxiv, 2023.12. 04.569946, 2023 | 1 | 2023 |
| Transcriptional suppression of sphingolipid catabolism controls pathogen resistance in C. elegans MA Nasrallah, ND Peterson, ES Szumel, P Liu, AL Page, SY Tse, ... PLoS Pathogens 19 (10), e1011730, 2023 | 1 | 2023 |
| Surveillance of Host and Pathogen Derived Metabolites Activates Intestinal Immunity ND Peterson UMass Chan Medical School, 2022 | | 2022 |
| A TIR-1/SARM1 phase transition underlies p38 immune pathway activation in theC. elegansintestine ND Peterson, JD Icso, JE Salisbury, T Rodríguez, PR Thompson, ... | | 2021 |
